Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial CONCEPTT)

Women with type 1 diabetes continue to have adverse pregnancy outcomes, including high rates of major congenital malformations, stillbirth, neonatal death, as well as macrosomia and its associated complications. This study will consist of two parallel trials that are multi-centered, randomized, open label, and controlled with an intention-to-treat analysis.

The sample size is 214 pregnant women and 110 pre-pregnant women, to be recruited from 28 centres in total with 10 in Canada and 18 internationally.

For more information on the CONCEPTT trial, please contact: